Compare PW & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PW | TNON |
|---|---|---|
| Founded | 1967 | 2012 |
| Country | United States | United States |
| Employees | N/A | 26 |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.5M |
| IPO Year | 2011 | 2021 |
| Metric | PW | TNON |
|---|---|---|
| Price | $7.46 | $3.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 1.9M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.90 | 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | $1,982,265.00 | ★ $3,944,000.00 |
| Revenue This Year | N/A | $65.95 |
| Revenue Next Year | N/A | $50.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.32 | ★ 20.35 |
| 52 Week Low | $0.50 | $0.13 |
| 52 Week High | $12.92 | $17.84 |
| Indicator | PW | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 33.17 | 47.19 |
| Support Level | $0.75 | $0.52 |
| Resistance Level | $8.20 | $7.15 |
| Average True Range (ATR) | 0.42 | 1.28 |
| MACD | -0.05 | -0.45 |
| Stochastic Oscillator | 34.08 | 0.07 |
Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.